hnRNP A1
Showing 1 - 25 of >10,000
Neurodevelopmental Disorders, Intellectual Disability, Developmental Delay Trial in New York
Recruiting
- Neurodevelopmental Disorders
- +6 more
-
New York, New YorkColumbia University Irving Medical Center
Nov 1, 2021
Febrile Illness Trial (Connex CSVM with Timmy3 module)
Not yet recruiting
- Febrile Illness
- Connex CSVM with Timmy3 module
- (no location specified)
Sep 25, 2023
Lactose Intolerance Trial in West Lafayette (Milk containing A1 and A2 beta-casein, Milk containing only A2 beta-casein)
Recruiting
- Lactose Intolerance
- Milk containing A1 and A2 beta-casein
- Milk containing only A2 beta-casein
-
West Lafayette, IndianaPurdue University
Dec 20, 2022
Lactose Intolerance Trial in West Lafayette (Milk containing A1 and A2 beta-casein, Milk containing only A2 beta-casein)
Recruiting
- Lactose Intolerance
- Milk containing A1 and A2 beta-casein
- Milk containing only A2 beta-casein
-
West Lafayette, IndianaPurdue University
Dec 20, 2022
Subcutaneous Fat Trial in Omaha (CBL-514 injection, CBL-A1 Injection, CBL-A2 Injection)
Not yet recruiting
- Subcutaneous Fat
- CBL-514 injection
- +3 more
-
Omaha, NebraskaInvestigational Site 1
Aug 17, 2023
GCF Annexin-A1, Carbonic Anhydrase-1, and Elongation Factor-1
Completed
- Periodontitis
- Periodontal Inflammation
- Peirodontal clinical measurements and gingival crevicular fluid sampling
-
İzmir, TurkeyDokuz Eylul University, Faculty of Dentistry, Department of Peri
Jan 10, 2023
Lactose Intolerance, Adult Type Trial in West Lafayette (Milk containing A1 and A2 beta-casein, Milk containing only A2
Active, not recruiting
- Lactose Intolerance, Adult Type
- Milk containing A1 and A2 beta-casein
- Milk containing only A2 beta-casein
-
West Lafayette, IndianaPurdue MRI Facility
Dec 17, 2022
Advanced Solid Tumor, Metastatic Solid Tumor, Lung Cancer Trial in Seoul, Incheon (WM-A1-3389, Pembrolizumab)
Not yet recruiting
- Advanced Solid Tumor
- +7 more
- WM-A1-3389
- Pembrolizumab
-
Seoul, Seocho-gu, Korea, Republic of
- +1 more
May 14, 2023
Healthy Infants Trial in China (a2 Platinum® stage 1 infant formula, Conventional, A1 and A2 ß-casein containing stage 1 infant
Completed
- Healthy Infants
- a2 Platinum® stage 1 infant formula
- Conventional, A1 and A2 β-casein containing stage 1 infant formula
-
Nanjing, Jiangsu, China
- +4 more
Nov 2, 2022
Advanced Solid Tumors Trial in Belgium, Germany, Spain (Autologous CD8+ T-cells, transduced with MAGE-A1 directed TCR)
Recruiting
- Advanced Solid Tumors
- Autologous CD8+ T-cells, transduced with MAGE-A1 directed TCR
-
Ghent, Belgium
- +2 more
Jun 23, 2022
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs
Not yet recruiting
- Myeloproliferative Neoplasms (MPNs)
- Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
- (no location specified)
Mar 24, 2023
Trigger Finger Trial in France (Percutaneous A1 Pulley Release Under Ultrasound Guidance, Corticosteroid injection)
Recruiting
- Trigger Finger
- Percutaneous A1 Pulley Release Under Ultrasound Guidance
- Corticosteroid injection
-
Créteil, France
- +3 more
May 31, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Solid Tumor Trial in
Suspended
- Anatomic Stage IV Breast Cancer AJCC v8
- +8 more
- Atezolizumab
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
May 23, 2022
US-guided Release of the A1 Pulley Responsible for Trigger Finger is Feasible With a 21-gauge Needle Trial in Assiut
Completed
- US-guided Release of the A1 Pulley Responsible for Trigger Finger is Feasible With a 21-gauge Needle
- ultrasonography-guided percutaneous A1 pulley needle release
-
Assiut, EgyptAssiut governorate
Dec 22, 2021
Mild Cognitive Impairment, Adults Trial (a2Milk skim milk powder, Yili skim milk powder)
Not yet recruiting
- Mild Cognitive Impairment
- Adults
- a2Milk skim milk powder
- Yili skim milk powder
- (no location specified)
Feb 14, 2023
Blood Pressure Trial in Shenzhen (wrist blood pressure monitor)
Completed
- Blood Pressure
- wrist blood pressure monitor
-
Shenzhen, Guangdong, ChinaShenzhen No.2 People's Hospital
Jul 28, 2022
Trigger Finger Trial in Atlanta (Excision of the A1 pulley, Incision of the A1 pulley in the standard fashion)
Not yet recruiting
- Trigger Finger
- Excision of the A1 pulley
- Incision of the A1 pulley in the standard fashion
-
Atlanta, Georgia
- +3 more
Jul 6, 2022
Cancer Trial in United States (SRK-181, anti-PD-(L)1 antibody therapy)
Recruiting
- Cancer
- SRK-181
- anti-PD-(L)1 antibody therapy
-
Fullerton, California
- +13 more
Jan 6, 2023
Multiple Myeloma Trial in Hackensack (Bortezomib)
Terminated
- Multiple Myeloma
-
Hackensack, New JerseyThe Cancer Center at Hackensack University Medical Center
Jun 24, 2022
Healthy Volunteers Trial in Lille (Group (A1 ? A2), Group (A2 ? A1))
Completed
- Healthy Volunteers
- Group (A1 → A2)
- Group (A2 → A1)
-
Lille, Nord, FranceNutrInvest - Institut Pasteur de Lille
Apr 5, 2022
Milk Intolerance Trial in Turku (Dietary intervention)
Recruiting
- Milk Intolerance
- Dietary intervention
-
Turku, FinlandFood Chemistry and Food Development, Department of Life Technolo
May 23, 2022
Sun Damaged Skin Trial in Detroit (Sunscreening Agents)
Active, not recruiting
- Sun Damaged Skin
- Sunscreening Agents
-
Detroit, MichiganDepartment of Dermatology, Henry Ford Medical Center, 3031 West
Jan 27, 2022
Oesophageal Adenocarcinoma, Squamous Cell Carcinoma, Solid Tumor Trial in United Kingdom (M6620, Cisplatin, Capecitabine)
Completed
- Oesophageal Adenocarcinoma
- +2 more
- M6620
- +3 more
-
Cardiff, United Kingdom
- +4 more
Apr 27, 2022